Randomized Controlled Trial
Copyright ©The Author(s) 2024.
World J Gastrointest Pharmacol Ther. Sep 5, 2024; 15(5): 97330
Published online Sep 5, 2024. doi: 10.4292/wjgpt.v15.i5.97330
Table 3 Cross-over effects and analysis details for abdominal pain

Effect
SE
DF
T value
P value
95%CI
Significance
Carryover-1.19130.6964163-1.71060.092-2.5830, 0.20038No
Treatment-5.14770.2899563-17.7540.000-5.7271, -4.5683Yes
Period-0.397730.2899563-1.37170.175-0.97714, 0.18169No